000 01449 a2200409 4500
005 20250517190921.0
264 0 _c20180817
008 201808s 0 0 eng d
022 _a1873-3492
024 7 _a10.1016/j.cca.2017.12.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSaentaweesuk, Waraporn
245 0 0 _aClinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis.
_h[electronic resource]
260 _bClinica chimica acta; international journal of clinical chemistry
_cFeb 2018
300 _a66-71 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcetylgalactosamine
_xblood
650 0 4 _aCholangiocarcinoma
_xblood
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPolysaccharides
_xblood
700 1 _aSilsirivanit, Atit
700 1 _aVaeteewoottacharn, Kulthida
700 1 _aSawanyawisuth, Kanlayanee
700 1 _aPairojkul, Chawalit
700 1 _aCha'on, Ubon
700 1 _aIndramanee, Somsiri
700 1 _aPinlaor, Somchai
700 1 _aBoonmars, Thidarut
700 1 _aAraki, Norie
700 1 _aWongkham, Chaisiri
773 0 _tClinica chimica acta; international journal of clinical chemistry
_gvol. 477
_gp. 66-71
856 4 0 _uhttps://doi.org/10.1016/j.cca.2017.12.005
_zAvailable from publisher's website
999 _c27866308
_d27866308